MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack "MIDNOR-TIA"

Completed

Phase N/A Results N/A

Update History

18 Oct '17
The Summary of Purpose was updated.
New
Patients with a transient ischemic attack (TIA) are at high risk of stroke. Rapid assessment and treatment can reduce the risk. Several international guidelines recommend a test, the ABCD2 score, to identify TIA patients with low and high risk for stroke. The main purpose of this study is to investigate stroke risk after TIA in both short (1 week) and long term (3 months/1 year), and to assess whether the Age, Blood pressure, Clinical features, Duration of TIA, Diabetes (ABCD2) score is a sufficient tool for predicting stroke risk. Secondary aims are to explore whether adopting imaging modalities (ultrasound, MRI) and biological markers of blood into a risk score could improve the predictive value of the ABCD2 score and still be feasible in a daily clinical practice. Further on overall risk factors in TIA patients, and the incidence of other vascular events will be studied. A substudy designed as a randomised controlled trial evaluates pharmaceutical counseling in a subset of participants. Cost-benefit analysis, and a long-term follow-up (5 years) is planned.
Old
Patients with a transient ischemic attack (TIA) are at high risk of stroke. Rapid assessment and treatment can reduce the risk. Several international guidelines recommend a test, the ABCD2 score, to identify TIA patients with low and high risk for stroke. The main purpose of this study is to investigate stroke risk after TIA in both short (1 week) and long term (3 months/1 year), and to assess whether the Age, Blood pressure, Clinical features, Duration of TIA, Diabetes (ABCD2) score is a sufficient tool for predicting stroke risk. Secondary aims are to explore whether adopting imaging modalities (ultrasound, MRI) and biological markers of blood into a risk score could improve the predictive value of the ABCD2 score and still be feasible in a daily clinical practice. Further on overall risk factors in TIA patients, and the incidence of other vascular events will be studied. A substudy designed as a randomised controlled trial evaluates pharmaceutical counseling in a subset of participants. Cost-benefit analysis, and a long-term follow-up (5 years) is planned.
The gender criteria for eligibility was updated to "All."
22 Jan '15
A location was updated in Kristiansund.
New
The overall status was removed for Kristiansund Sykehus.
A location was updated in Levanger.
New
The overall status was removed for Levanger Sykehus.
A location was updated in Molde.
New
The overall status was removed for Molde Sykehus.
A location was updated in Namsos.
New
The overall status was removed for Namsos Sykehus.
A location was updated in Orkanger.
New
The overall status was removed for Orkdal Sykehus.
A location was updated in Trondheim.
New
The overall status was removed for St Olavs Hospital.
A location was updated in Volda.
New
The overall status was removed for Volda Sykehus.
A location was updated in Ă…lesund.
New
The overall status was removed for Ă…lesund Sykehus.